| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |